Primary Antitumor Immune Response Mediated by CD4+ T Cells
Top Cited Papers
- 1 March 2005
- Vol. 22 (3) , 371-383
- https://doi.org/10.1016/j.immuni.2005.02.003
Abstract
No abstract availableKeywords
Funding Information
- Kreftforeningen
- Norges Forskningsråd
This publication has 38 references indexed in Scilit:
- Anti‐Class II Antibodies, but not Cytotoxic T‐Lymphocyte Antigen 4–Immunoglobulin Hybrid Molecules, Prevent Rejection of Major Histocompatibility Complex Class II‐Negative Myeloma in T‐Cell Receptor‐Transgenic MiceScandinavian Journal of Immunology, 2004
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor DevelopmentThe Journal of Experimental Medicine, 2002
- Regulation of Cutaneous Malignancy by γδ T CellsScience, 2001
- Dendritic Cells Infiltrating Tumors Cotransduced with Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf) and Cd40 Ligand Genes Take up and Present Endogenous Tumor-Associated Antigens, and Prime Naive Mice for a Cytotoxic T Lymphocyte ResponseThe Journal of Experimental Medicine, 1999
- Tumor Cell Responses to IFNγ Affect Tumorigenicity and Response to IL-12 Therapy and AntiangiogenesisImmunity, 1998
- Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative TumorsThe Journal of Experimental Medicine, 1998
- In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.The Journal of Experimental Medicine, 1994
- The Role of Idiotype-Specific, CD4+ T Cells in Tumor Resistance against Major Histocompatibility Complex Class II Molecule Negative Plasmacytoma CellsCellular Immunology, 1993